According to the latest data from the Hong Kong Stock Exchange, on November 10, Lazard Asset Management LLC reduced its holdings in SINOPHARM (01099) by 5.9856 million shares at a price of HK$17.12 per share, for a total amount of approximately HK$102 million.
Following the reduction, its latest shareholding stands at approximately 187 million shares, representing a stake of 13.92%.